Although there was clearly decreasing trend of the total count of CD3+CD4+ from group A towards group D, statistical significance of the differences between low symptom group (A) versus ICU group (Group C; p = 0.06) and patients with severe COVID-19 (Group B) compared to deceased patients (Group D; p = 0.059) was only borderline. This evidence concerns the gene CD4 and COVID-19.